KRAS and neoplasm: In addition to this, PDAC has driver mutations such as Kirsten’s rat sarcoma viral oncogene homologue (KRAS) and tumor protein p53 (TP53) which can synergize to exert a vast range of growth and tumor supporting signals [8,9].